FLGC: Total Utang marang Modal Flora Growth Corporation

This daily price chart for Flora Growth Corp. (FLGC) with the 0.05 indicator confirms a diversification strategy driven by multi-brand ownership and international exports. The current trend is fueled by the completion of restructuring under K. Strub and a strategic pivot toward the US wellness market. The business's unit economics rely on Colombian plantations with minimal costs, which, combined with global logistics, optimizes overall expenditures.

floragrowth.ca (FLGC): Rasio Kabeh Utang marang Dana Pribadi saka 04.07.2022 nganti 29.01.2026

Rincian metrik lan analitis perusahaan Flora Growth Inc (FLGC)

- rega lan prakiraan konsensus rega:

Bagan rega Flora Growth|FLGC - Prakiraan gabungan firma investasi

- informasi kapitalisasi pasar:

Kapitalisasi pasar Flora Growth|FLGC - Nilai Perusahaan

- indikator kapitalisasi buku:

Aset Bersih saben Siji Saham Flora Growth|FLGC - Nilai Akuntansi Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku floragrowth.ca|FLGC - Gunggung Aset Perusahaan

- rincian utang lan likuiditas:

Utang marang Ekuitas Flora Growth Corp.|FLGC - Kewajiban jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas Flora Growth Corp.|FLGC - Kewajiban utang agregat|Utang-utang marang kapitalisasi buku Flora Growth|FLGC - Kewajiban jangka dawa|Utang jangka cendhak perusahaan Flora Growth

Pambiji fundamental perusahaan:Flora Growth, FLGC

The dynamics of the liability structure, specifically the total debt-to-equity ratio, reflect the financing efficiency of Flora Growth Corp. (FLGC) automated plantations and laboratories in Colombia and Germany. This ratio compares total credit obligations to shareholders' equity to determine the degree of financial leverage; low values confirm the business's resilience to bankruptcy, whereas excessive leverage may indicate risks when scaling high-tech production.

Karo sapa Flora Growth Corp. saingan

Utang marang Ekuitas Indivior|Rasio Utang marang Ekuitas COLL (Collegium Pharma)|Total Utang marang Modal CRON|Total Utang marang Modal Canopy Growth Corp. (CGC)|Utang marang Ekuitas High Tide Inc. HITI|Rasio Kabeh Utang marang Dana Pribadi ACB|Achieve Life Sciences, Inc. - Total Utang marang Modal|Skye Bioscience Inc. (SKYE) - Rasio Total Utang marang Ekuitas|Anebulo (ANEB) - Utang marang Ekuitas|Utang marang Modal InterCure (INCR)|Rasio Total Utang marang Ekuitas NTRB|NSRX: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal IGC|MIRA: Utang Agregat marang Ekuitas|Total Utang marang Modal IMCC (IM Cannabis)|Total Utang marang Modal Adial Pharmaceuticals Inc. ADIL|ARTL - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi ENSC (Ensysce Biosciences)|titanpharm.com (TTNP) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Greenlane Holdings, Inc.|INM (InMed Pharma) - Total Utang marang Modal|Akanda Inc - Utang Agregat marang Ekuitas|Utang marang Ekuitas Enveric Biosciences (ENVB)|Utang marang Ekuitas BGXX (brightgreen.us)|Utang marang Ekuitas Hempacco Co., Inc. HPCO